论文部分内容阅读
抗结核药物的应用,改变了人工气胸治疗的适应证,在新发病的早期结核时,其应用范围却部分地缩小了,而那些以前很受限制的病例,其应用的指徵则放宽了。很多作者均指出人工气胸疗效之增高,与抗结核疗法的应用有关,甚至提出了当进行综合治疗时有可能缩短人工气胸期限等问题。本文之目的,就是要探讨人工气胸与抗结核药物合并应用的效果问题。我们研究了172例患者的病历,这些患者都是在抗结核治疗的基础上开始应用人工气胸术的,而在最初1—2
The use of anti-tuberculosis drugs has changed the indications for the treatment of artificial pneumothorax. In the early stages of new tuberculosis, the scope of its application has been reduced in part, and the indications for its application have been relaxed in those cases that were previously restricted. Many authors have pointed out that the increase in the efficacy of artificial pneumothorax is related to the application of anti-tuberculosis therapy, and even raised the issue of the possibility of shortening the duration of artificial pneumothorax when performing comprehensive treatment. The purpose of this article is to investigate the effect of the combined application of artificial pneumothorax and anti-tuberculosis drugs. We studied the medical records of 172 patients who started the application of artificial pneumothorax on the basis of anti-tuberculosis treatment, and in the first 1-2